For some people with a high risk of Alzheimer's who received a drug called gantenerumab for eight years, their risk of ...

A research team has identified a previously unknown enzyme, SIRT2, that plays a key role in memory loss associated with Alzheimer's disease (AD). The study provides critical insights into how ...

Tim-3 is an immune checkpoint molecule involved in immunity and inflammation recently linked to late-onset Alzheimer's disease (AD), but its role in the brain was unknown until now. Researchers used ...

FRIDAY, April 4, 2025 (HealthDay News) -- An experimental blood test for Alzheimer’s disease not only can aid in its diagnosis but also indicate how far the brain condition has progressed ...

An experimental treatment appears to delay Alzheimer’s symptoms in some people genetically destined to get the disease in their 40s or 50s, according to new findings from ongoing research now ...

Amyloid beta plaques, lumps of waste protein that accumulate in the brain, have long been understood as a key factor in the development of Alzheimer’s disease. Many proposed Alzheimer’s ...

The outlook for preventing, diagnosing and treating Alzheimer’s disease is brighter than it’s ever been. The field has started to achieve tangible successes in moving basic biological insights ...

Alzheimer’s disease doesn’t arrive suddenly. Instead, it emerges slowly, beginning with subtle changes that might be dismissed as normal aging before progressing through increasingly serious ...

Joe Napsha Thursday, Aug. 8, 2024 5:45 a.m. | Thursday, Aug. 8, 2024 5:45 a.m. More information Those who want to be evaluated by Independence Health Sytem's neurology department can contact the ...